Search

everythinglearnresearchcommunity

for

Search:↓

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

Properly monitored hormone therapy can improve life quality, but misuse can cause serious health issues.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

The treatment successfully lowered testosterone levels and reduced symptoms.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Gender-affirming hormone therapy may increase heart disease risk in transgender individuals.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Testosterone treatment may affect heart response to stress in transgender men.

Treat hirsutism in premenopausal women with oral contraceptives and consider additional treatments if needed.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.